Cargando…
Peritumoral Delivery of Docetaxel‐TIPS Microparticles for Prostate Cancer Adjuvant Therapy
Recurrence of prostate cancer after radical prostatectomy is a consequence of incomplete tumor resection. Systemic chemotherapy after surgery is associated with significant toxicity. Improved delivery methods for toxic drugs capable of targeting positive resection margins can reduce tumor recurrence...
Autores principales: | Paliashvili, Ketevan, Popov, Alexander, Kalber, Tammy L., Patrick, P. Stephen, Hayes, Angela, Henley, Alan, Raynaud, Florence I., Ahmed, Hashim U., Day, Richard M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427470/ https://www.ncbi.nlm.nih.gov/pubmed/34527807 http://dx.doi.org/10.1002/adtp.202000179 |
Ejemplares similares
-
Functionalised thermally induced phase separation (TIPS) microparticles enabled for “click” chemistry
por: Nogueira, João C. F., et al.
Publicado: (2020) -
A novel adjuvant drug-device combination tissue scaffold for radical prostatectomy
por: Paliashvili, Ketevan, et al.
Publicado: (2019) -
Role of intratumoral and peritumoral CT radiomics for the prediction of EGFR gene mutation in primary lung cancer
por: Yamazaki, Motohiko, et al.
Publicado: (2022) -
Docetaxel: an alternative taxane in ovarian cancer
por: Katsumata, N
Publicado: (2003) -
Docetaxel: promising and novel combinations in ovarian cancer
por: Mäenpää, J U
Publicado: (2003)